In 2020, cancer diagnoses will thrust nearly 2 million Americans into the often bewildering world of treatments and clinical trials. TrialJectory aims to help. The service uses AI to read through thousands of clinical trials and extract information about the sorts of patients the researchers are looking for. Its algorithm then matches users with the clinical trials—like the one a patient found for her Stage IV metastatic breast cancer—based on the users’ responses to a series of questions about themselves and their disease progression. Since launching in 2018, TrialJectory’s researchers have expanded the system to cover more types of cancer, adding lung cancers this summer. —Alejandro de la Garza
More Must-Read Stories From TIME
- Want to Do More Good? This Movement Might Have the Answer
- What to Know About the Monkeypox Drug TPOXX—And Why It's So Hard to Get
- The Year's Final Supermoon Reminds Us Why We Love the Night Sky
- A Hotter World Means More Disease Outbreaks in Our Future
- How The Sandman Author Neil Gaiman Drew Inspiration From His Nightmares
- Candace Parker Is a Force in Basketball and Beyond
- Dropbox Tossed Out the Workplace Rulebook. Here’s How That’s Working